Used as a key chiral intermediate in the synthesis of prostaglandin analogs, particularly in the production of ophthalmic drugs for treating glaucoma. Its stereochemistry enables selective biological activity, making it valuable in developing medications that reduce intraocular pressure. The compound's structure allows efficient coupling in multi-step syntheses of active pharmaceutical ingredients, especially in agents like latanoprost or similar prostaglandin derivatives. Its fluorinated aromatic group enhances metabolic stability and target binding affinity.